Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
High mobility group B1 (HMGB1) is a protein that is released from dying cancer cells in the context of immunogenic cell death (ICD). A recent study performed on patients with head and neck squamous cell carcinomas (HNSCC) reports that a chemoradiotherapy-induced increase in circulating HMGB1 levels...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Taylor & Francis Group
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/d1c3818d0e244f189784f14b906aeefd |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|